Literature DB >> 15686452

Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective.

R E Hough1, J A Snowden, N M Wulffraat.   

Abstract

The potential of haemopoietic stem cell transplantation (HSCT) for the treatment of autoimmune and inflammatory diseases was originally supported by almost three decades of animal experiments and by the serendipitous remissions of autoimmune disease observed in patients undergoing transplantation for haematological disorders. Improved safety of both autologous and allogeneic HSCT over the last decade has been followed by increasing acceptance of HSCT as an experimental treatment for severe autoimmune diseases that are resistant to conventional treatment. International databases have collated over 700 procedures performed specifically for a variety of autoimmune diseases. Phase III clinical trials are in progress for some diseases. This review provides a comprehensive update on the efficacy and toxicity of HSCT in severe autoimmune disease. Future directions in the context of other evolving therapies are discussed.

Entities:  

Mesh：

Year:  2005        PMID： 15686452     DOI： 10.1111/j.1365-2141.2004.05298.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  10 in total

1.  Bone marrow transplantation with a reduced-intensity conditioning regimen in a patient with Wegener granulomatosis and therapy-related leukemia.

Authors:  Akane Kunitomi; Takayuki Ishikawa; Kenichirou Tajima; Yoshiteru Konaka; Masato Yagita
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Significant improvement of Takayasu arteritis after cord blood transplantation in a patient with myelodysplastic syndrome.

Authors:  H Kato; Y Onishi; S Nakajima; Y Okitsu; N Fukuhara; T Fujiwara; M Yamada-Fujiwara; J Kameoka; K Ishizawa; H Harigae
Journal:  Bone Marrow Transplant       Date:  2013-12-09       Impact factor: 5.483

3.  Resolution of celiac disease, IgA deficiency and platelet refractoriness after allogeneic bone marrow transplantation for acute leukemia.

Authors:  Sasan Zandi; Solaf Kanfar; Christine Cserti-Gazdewich; Jeffrey H Lipton; Jacob Pendergrast
Journal:  Haematologica       Date:  2019-01-17       Impact factor: 9.941

4.  Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases.

Authors:  John A Snowden; Manuela Badoglio; Myriam Labopin; Sebastian Giebel; Eoin McGrath; Zora Marjanovic; Joachim Burman; John Moore; Montserrat Rovira; Nico M Wulffraat; Majid Kazmi; Raffaella Greco; Emilian Snarski; Tomas Kozak; Kirill Kirgizov; Tobias Alexander; Peter Bader; Riccardo Saccardi; Dominique Farge
Journal:  Blood Adv       Date:  2017-12-20

5.  Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Authors:  Dominique Farge; Myriam Labopin; Alan Tyndall; Athanasios Fassas; Gian Luigi Mancardi; Jaap Van Laar; Jian Ouyang; Tomas Kozak; John Moore; Ina Kötter; Virginie Chesnel; Alberto Marmont; Alois Gratwohl; Riccardo Saccardi
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

6.  Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.

Authors:  James L M Ferrara
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-12       Impact factor: 5.742

7.  Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.

Authors:  Juliana M F Silva; Fani Ladomenou; Ben Carpenter; Sharat Chandra; Petr Sedlacek; Renata Formankova; Vicky Grandage; Mark Friswell; Andrew J Cant; Zohreh Nademi; Mary A Slatter; Andrew R Gennery; Sophie Hambleton; Terence J Flood; Giovanna Lucchini; Robert Chiesa; Kanchan Rao; Persis J Amrolia; Paul Brogan; Lucy R Wedderburn; Julie M Glanville; Rachael Hough; Rebecca Marsh; Mario Abinun; Paul Veys
Journal:  Blood Adv       Date:  2018-04-10

8.  Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines.

Authors:  D M C Brinkman; C M Jol-van der Zijde; M M ten Dam; P A W te Boekhorst; R ten Cate; N M Wulffraat; R Q Hintzen; J M Vossen; M J D van Tol
Journal:  J Clin Immunol       Date:  2007-08-10       Impact factor: 8.317

9.  Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Authors:  J A Snowden; R Saccardi; M Allez; S Ardizzone; R Arnold; R Cervera; C Denton; C Hawkey; M Labopin; G Mancardi; R Martin; J J Moore; J Passweg; C Peters; M Rabusin; M Rovira; J M van Laar; D Farge
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

Review 10.  Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives.

Authors:  Mohammad Mominur Rahman; Mohammad Rezaul Islam; Mohammad Touhidul Islam; Mohammad Harun-Or-Rashid; Mahfuzul Islam; Sabirin Abdullah; Mohammad Borhan Uddin; Sumit Das; Mohammad Saidur Rahaman; Muniruddin Ahmed; Fahad A Alhumaydhi; Talha Bin Emran; Amany Abdel-Rahman Mohamed; Mohammad Rashed Iqbal Faruque; Mayeen Uddin Khandaker; Gomaa Mostafa-Hedeab
Journal:  Biology (Basel)       Date:  2022-01-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.